Morgan Stanley initiated coverage on Amicus Therapeutics with a new price target
$FOLD
Biotechnology: Pharmaceutical Preparations
Health Care
Morgan Stanley initiated coverage of Amicus Therapeutics with a rating of Equal-Weight and set a new price target of $14.00